Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for IPSEN (IPSEY : OTC)

• Company Description    Ipsen S.A. is a pharmaceutical company. It provide drugs for urology, oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology and cardiovascular. Ipsen S.A. is headquartered in Boulogne-Billancourt, France. Number of Employees: 5,358

• Price / Volume Information    Yesterday's Closing Price: $44.81 Daily Weekly Monthly 20 Day Moving Average: 742 shares Shares Outstanding: 335.26 (millions) Market Capitalization: $15,022.91 (millions) Beta: 0.41 52 Week High: $51.10 52 Week Low: $30.05 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -3.63% -4.34% 12 Week -8.71% -11.21% Year To Date 23.24% 19.72%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 65 quai Georges Gorse - Boulogne-Billancourt cedex,I0 92100 FRA ph: 33-01-58-33-50-00 fax: 33-01-58-33-50-01 investor.relations@ipsen.com http://www.ipsen.com

• General Corporate Information    Officers David Loew - Chief Executive Officer Marc de Garidel - Chairman Aymeric Le Chatelier - Executive Vice-President; Chief Financial Officer Karen Witts - Director Carol Xueref - Director Peer Information IPSEN (GSAC) IPSEN (CASIF) IPSEN (ALCD.) IPSEN (OMNN) IPSEN (CGPI.) IPSEN (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 462629205 SIC: 2835 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 335.26 Most Recent Split Date: (:1) Beta: 0.41 Market Capitalization: $15,022.91 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.67% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.30 Current Fiscal Year EPS Consensus Estimate: $3.84 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 06/04/2026 - $0.30 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: 11.68 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.06 Price/Cash Flow: 8.13 Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/26 - - 03/31/26 - - 12/31/25 - - ROA 06/30/26 - - 03/31/26 - - 12/31/25 - - Current Ratio 06/30/26 - - 03/31/26 - - 12/31/25 - 1.96 Quick Ratio 06/30/26 - - 03/31/26 - - 12/31/25 - 1.79 Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - - 03/31/26 - - 12/31/25 - 14.73 Book Value 06/30/26 - - 03/31/26 - - 12/31/25 - 14.64 Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - 3.03 Debt-to-Equity 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Capital 06/30/26 - - 03/31/26 - - 12/31/25 - -

Powered by Zacks Investment Research ©